Literature DB >> 7439981

Intestinal immune response to cholera toxin: dependence on route and dosage of antigen for priming and boosting.

A M Svennerholm, S Lange, J Holmgren.   

Abstract

The influence in immunization with cholera toxin of the route and antigen dose on intestinal antibody formation and protective immunity against experimental cholera was studied in mice. Administration by either the intravenous or oral route induced effective priming as well as boosting of mucosal immunity, with the effects on intestinal immunoglobulin A antitoxin synthesis and protective antitoxic immunity showing excellent concordance. A strong antigen dose dependence was found for both priming and boosting of the local immunity, irrespective of route. Very efficient high-dose priming did, however, partially decrease the dose dependence of the booster response and, conversely, a high booster dose partly overcame the relative inefficiency of low-dose priming. The results suggest that the amount of antigen reaching the immunocompetent cells in the gut rather than the route of administration per se determines the mucosal immunizing effect.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7439981      PMCID: PMC551315          DOI: 10.1128/iai.30.2.337-341.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  10 in total

1.  Cholera toxin, ganglioside receptors and the immune response.

Authors:  J Holmgren; L Lindholm
Journal:  Immunol Commun       Date:  1976

2.  Local cholera immunity in mice: intestinal antitoxin-containing cells and their correlation with protective immunity.

Authors:  S Lange; H A Hansson; S O Molin; H Nygren
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

3.  Experimental studies on cholera immunization. II. Evidence for protective antitoxic immunity mediated by serum antibodies as well as local antibodies.

Authors:  J Holmgren; A Andersson; G Wallerstrom; O Ouchterlony
Journal:  Infect Immun       Date:  1972-05       Impact factor: 3.441

4.  Development of improved cholera vaccine based on subunit toxoid.

Authors:  J Holmgren; A M Svennerholm; I Lönnroth; M Fall-Persson; B Markman; H Lundbeck
Journal:  Nature       Date:  1977-10-13       Impact factor: 49.962

5.  Enzyme-linked immunosorbent assays for cholera serology.

Authors:  J Holmgren; A M Svennerholm
Journal:  Infect Immun       Date:  1973-05       Impact factor: 3.441

6.  Protective antitoxic cholera immunity in mice: influence of route and number of immunizations and mode of action of protective antibodies.

Authors:  S Lange; J Holmgren
Journal:  Acta Pathol Microbiol Scand C       Date:  1978-08

7.  Boosting of secretory IgA antibody responses in man by parenteral cholera vaccination.

Authors:  A M Svennerholm; J Holmgren; L A Hanson; B S Lindblad; F Quereshi; R J Rahimtoola
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

8.  Correlation between intestinal synthesis of specific immunoglobulin A and protection against experimental cholera in mice.

Authors:  A Svennerholm; S Lange; J Holmgren
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

9.  The role of antigen form and function in the primary and secondary intestinal immune responses to cholera toxin and toxoid in rats.

Authors:  N F Pierce
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

10.  Cellular kinetics of the intestinal immune response to cholera toxoid in rats.

Authors:  N F Pierce; J L Gowans
Journal:  J Exp Med       Date:  1975-12-01       Impact factor: 14.307

  10 in total
  4 in total

1.  Systemic delayed-type hypersensitivity to cholera toxin and a detoxified derivative.

Authors:  R A Kay; A Ferguson
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

2.  Induction of optimal mucosal antibody responses: effects of age, immunization route(s), and dosing schedule in rats.

Authors:  N F Pierce
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

3.  Oral immunization of dogs with purified cholera toxin, crude cholera toxin, or B subunit: evidence for synergistic protection by antitoxic and antibacterial mechanisms.

Authors:  N F Pierce; W C Cray; J B Sacci
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

Review 4.  Peyer's patches: organizing B-cell responses at the intestinal frontier.

Authors:  Andrea Reboldi; Jason G Cyster
Journal:  Immunol Rev       Date:  2016-05       Impact factor: 12.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.